Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
Article in The Lancet Neurology (February 2023)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in The Lancet Neurology (February 2023)
Article in European Spine Journal (September 2022)
Article in Genes (November 2021)